Señales en vivo de MNKD | Maximiza tus Ganancias con Getagraph.com

VENDER 111395 min ago

@ $3.58

Emitido: 14 feb 2024 @ 14:32

Retorno: 21.40%

Señal anterior: feb 14 - 13:57

Señal anterior: Comprar

Retorno: 1.56 %

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States...

Stats
Volumen de hoy	2.51M
Volumen promedio	2.92M
Capitalización de mercado	1.17B
EPS	$0 ( 2024-02-27 )
Próxima fecha de ganancias	( $0.0200 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-108.50
ATR14	$0.00800 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-22	Prentiss Christopher B	Buy	0
2024-03-27	Sabella Lauren M	Sell	17 084	Common Stock, $.01 Par Value
2024-02-04	Tross Stuart A	Buy	15 290	Common Stock, $0.01 Par Value
2023-12-31	Tross Stuart A	Buy	1 006	Common Stock, $0.01 Par Value
2023-06-30	Tross Stuart A	Buy	4 012	Common Stock, $0.01 Par Value

INSIDER POWER
30.57
Last 95 transactions
Buy: 5 237 724 \| Sell: 2 722 728

Volumen Correlación

Largo: -0.05 (neutral)

Corto: -0.92 (very strong negative)

Signal:(44.318) Neutral

MannKind Corp Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MannKind Corp Correlación - Moneda/Commodity

0.56
( weak )

0.45
( neutral )

0.00
( neutral )

-0.19
( neutral )

MannKind Corp Finanzas

Annual	2023
Ingresos:	$198.96M
Beneficio Bruto:	$136.19M (68.45 %)
EPS:	$-0.0447

FY	2023
Ingresos:	$198.96M
Beneficio Bruto:	$136.19M (68.45 %)
EPS:	$-0.0447

FY	2022
Ingresos:	$99.77M
Beneficio Bruto:	$42.27M (42.37 %)
EPS:	$-0.440

FY	2021
Ingresos:	$75.44M
Beneficio Bruto:	$36.59M (48.49 %)
EPS:	$-0.320

Financial Reports:

No articles found.

MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.